Skip to content

Safety of high-flow nasal cannula oxygen therapy for extubation under deep anesthesia in patients with hypertension: a randomized controlled trial

Safety of high-flow nasal cannula oxygen therapy for extubation under deep anesthesia in patients with hypertension: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110965
Enrollment
Unknown
Registered
2025-10-23
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensionn

Interventions

GroupH:HFNC was administered after extubation under deep anesthesia.
Group C:Normal trachea was extubated.

Sponsors

Gansu Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed hypertension; 2.ASA I-III, aged 18-65 yr, 18<BMI<30kg/m^2; 3. no history of serious brain, liver or kidney diseases; 4. The patients were reviewed by the ethics committee and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with known or estimated difficult airway; 2. History of severe or uncontrolled chronic obstructive pulmonary disease (severity III or IV), severe or uncontrolled bronchial asthma, pulmonary infection, or bronchiectasis; 3. Thoracic deformities and diseases (such as mediastinal and thoracic tumors); 4. Acute coronary syndrome, sustained ventricular tachyarrhythmia (NYHA class III or IV), severe heart disease; 5. Severe neuromuscular diseases; 6. Previous respiratory or periairway surgery (including thyroid surgery).

Design outcomes

Primary

MeasureTime frame
Incidence of hypoxemia;

Secondary

MeasureTime frame
Baseline characteristics and population;Operation time;Occurrence of vomiting, agitation, hypertension, and tachycardia in patients;Basic vital signs:Heart rate (HR), mean arterial pressure (MAP), oxygen saturation (spo2), tidal volume (VT) and respiratory rate (RR) were measured before extubation (T1), after extubation (T2) and 10min after extubation (T3);Arterial blood gas analysis was performed before surgery, at the time of entering the PACU, and 10min after extubation. PaO2, PaCO2, PH, SaO2, HCO3, and Lac were measured;Other adverse events;Tolerance score, agitation during recovery period and oropharyngeal pain after recovery were evaluated;

Countries

China

Contacts

Public ContactShi Lei

Gansu Provincial People's Hospital

765219767@qq.com+86 199 9535 0782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026